To ensure a rapid processing of your application, please apply only via the “Apply” button. Please include a letter of motivation and a current resume with your application.

As Key Expert MSAT Upstream Processing (USP) within our MSAT Recombinant Drug Substance Microbial team, you'll develop, optimize, and transfer upstream bioprocesses for biotechnological manufacturing of peptides and proteins, specifically for our new insulin facility in Beijing. Ready to get started?

Sanofi has decided to invest into new large state-of-the art facilities for the full portfolio for insulin drug substances to ensure future oriented, sustainable, reliable and leading-edge long-term supply for world-wide diabetes patients. The new facilities will be designed as a fully automated, green, modern and state-of-the-art biologics facility considering specific process requirements of all insulins. The localization of those facilities will be in Frankfurt, Germany and Beijing, Chin...